73
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy

, , , &
Pages 49-57 | Published online: 20 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tingjian Yan, Mallik Greene, Eunice Chang, Christy R Houle, Marian H Tarbox & Michael S Broder. (2020) Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder. ClinicoEconomics and Outcomes Research 12, pages 81-89.
Read now
Amany K. Hassan, Kevin C. Farmer, Nancy C. Brahm, Shellie Keast, Nancy Nesser & Barbara R. Neas. (2016) Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings? Comparing healthcare costs and utilization between second-line treatment options. Journal of Mental Health 25:6, pages 486-491.
Read now

Articles from other publishers (7)

Yawen Jiang & Weiyi Ni. (2019) Factors related to the comparative effectiveness of clozapine in patients with schizophrenia. Journal of Comparative Effectiveness Research 8:3, pages 179-185.
Crossref
Weiyi Ni, Danielle Colayco, Jonathan Hashimoto, Kevin Komoto, Chandrakala Gowda, Bruce Wearda & Jeffrey McCombs. (2018) Reduction of healthcare costs through a transitions-of-care program. American Journal of Health-System Pharmacy 75:10, pages 613-621.
Crossref
Yawen Jiang & Weiyi Ni. (2015) Health Care Utilization and Treatment Persistence Associated with Oral Paliperidone and Lurasidone in Schizophrenia Treatment. Journal of Managed Care & Specialty Pharmacy 21:9, pages 780-792.
Crossref
Yazed Sulaiman Al-Ruthia, Song Hee Hong & David Solomon. (2015) Do depressed patients on adjunctive atypical antipsychotics demonstrate a better quality of life compared to those on antidepressants only? A comparative cross-sectional study of a nationally representative sample of the US population. Research in Social and Administrative Pharmacy 11:2, pages 228-240.
Crossref
Rao N. Malempati. (2015) Aripiprazole Adjunct Treatment in Bipolar I or II Disorder, Depressed State. Journal of Nervous & Mental Disease 203:1, pages 58-64.
Crossref
Andrea de Bartolomeis, Livia Avvisati, Felice Iasevoli & Carmine Tomasetti. (2013) Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment. European Journal of Pharmacology 718:1-3, pages 502-523.
Crossref
Rachel Halpern, Anagha Nadkarni, Iftekhar Kalsekar, Hiep Nguyen, Rui Song, Ross A Baker & J Craig Nelson. (2013) Medical Costs and Hospitalizations Among Patients with Depression Treated with Adjunctive Atypical Antipsychotic Therapy: An Analysis of Health Insurance Claims Data. Annals of Pharmacotherapy 47:7-8, pages 933-945.
Crossref